Language
English
Publication Date
7-11-2025
Journal
Nature Communications
DOI
10.1038/s41467-025-61595-3
PMID
40645925
PMCID
PMC12254204
PubMedCentral® Posted Date
7-11-2025
PubMedCentral® Full Text Version
Post-print
Abstract
Respiratory syncytial virus (RSV) is a significant cause of morbidity and mortality in high-risk populations. Although prophylactic options are available, there are no effective oral therapeutics for RSV infection. Obeldesivir (ODV) is an orally bioavailable prodrug of the nucleoside analog GS-441524, which is converted intracellularly to its active nucleoside triphosphate and inhibits the RSV RNA polymerase. Here we report the potent antiviral activity of ODV against geographically and temporally diverse RSV A and B clinical isolates (EC50: 0.20–0.66 μM). Resistance selection studies with ODV and GS-441524 against RSV identify a single amino acid substitution, I777L, in the L polymerase with reduced susceptibility (3.3-3.8-fold) to ODV and GS-441524, indicating a high barrier for resistance development. In an African green monkey RSV infection model, once-daily oral ODV doses of 30 or 90 mg/kg initiated ~24 hours post-infection significantly reduces log10 viral RNA copies/mL × day area under the curve by 69–92% in the upper and lower respiratory tracts. Together, these preclinical data support the clinical evaluation of ODV for the treatment of RSV infection.
Keywords
Animals, Chlorocebus aethiops, Antiviral Agents, Respiratory Syncytial Virus Infections, Administration, Oral, Humans, Respiratory Syncytial Virus, Human, Drug Resistance, Viral, Female, Disease Models, Animal, Nucleosides, Adenosine, Antiviral agents, Pharmacodynamics
Published Open-Access
yes
Recommended Citation
Pitts, Jared; Zamora, J Lizbeth Reyes; Manhas, Savrina; et al., "Oral Dosing of the Nucleoside Analog Obeldesivir Is Efficacious Against Rsv Infection in African Green Monkeys" (2025). Faculty and Staff Publications. 4823.
https://digitalcommons.library.tmc.edu/baylor_docs/4823
Included in
Health Services Research Commons, Medical Molecular Biology Commons, Medical Specialties Commons, Virology Commons